December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
IRBP Mutants: Retinoid Binding and Protective Capabilities
Author Affiliations & Notes
  • JF Mowbray
    Ophthalmology University of Virginia Charlottesville VA
  • J Thiagarajah
    Ophthalmology University of Virginia Charlottesville VA
  • E Van Niel
    Ophthalmology University of Virginia Charlottesville VA
  • A Loew
    Abbott Bioresearch Center Inc Worcester MA
  • F Gonzalez-Fernandez
    Ophthalmology University of Virginia Charlottesville VA
  • Footnotes
    Commercial Relationships   J.F. Mowbray, None; J. Thiagarajah, None; E. Van Niel, None; A. Loew, None; F. Gonzalez-Fernandez, None. Grant Identification: EY09412
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3607. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JF Mowbray, J Thiagarajah, E Van Niel, A Loew, F Gonzalez-Fernandez; IRBP Mutants: Retinoid Binding and Protective Capabilities . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3607.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Crouch et al. (Photochem & Photobiol 56: 251-255, 1992) showed that interphotoreceptor retinoid binding protein (IRBP) has a remarkable but not yet understood ability to protect retinoids from oxidative/isomeric degradation. Toward understanding the mechanism of this protection we have recently elucidated a structural homology between IRBP, photosystem II D1 C-terminal processing protease, and the enoyl-CoA isomerase/hydratase family, suggesting a common fold used in diverse settings ranging from proteolysis, to fatty acid isomerization to retinoid transport (Loew and Gonzalez-Fernandez. Structure, in press). Purpose:To determine whether interactions between IRBP and retinoids are affected by mutations in the putative ligand-binding fold. Methods:We expressed in E. coli the second module of Xenopus IRBP as a soluble thioredoxin fusion protein (X2IRBP). To date, V186H, E217D, and E217H were created and purified. Each substitution was confirmed by mass spectrometry and protein concentration determined by amino-acid analysis. The stoichiometry and Kd of all-trans retinol binding to X2IRBP and its mutants were determined by fluorescence spectroscopy. The ability of the recombinant proteins to protect all-trans retinol from oxidative degradation was evaluated by monitoring the absorbance of the complex at 325 nm over time. Results:X2IRBP: N = 1.57 +/- 0.074; Kd = 0.11 +/- 0.042. This data is virtually identical to that reported by Loew et al. (Exp Eye Res 73: 257-264, 2001). E217H: N = 2.18 +/- 0.22; Kd = 0.08 +/- 0.06. E217D: N = 0.88 +/- 0.11; Kd = 0.11 +/- 0.10. V186H: N = 1.71 +/- 0.05; Kd = 0.03 +/- 0.04. When complexed to the mutants, retinol oxidation was 2.5 to 4.6 times faster than when bound to X2IRBP. Conclusion:These mutants demonstrate a slight change in number of binding sites and Kd and appear to be deficient in their ability to protect against oxidative degradation. This is in contrast to our previous data showing no functional difference when residues outside of the fold were mutated (Baer et al. Mol Vis. 4:30, 1998).

Keywords: 527 protein structure/function • 571 retinoids/retinoid binding proteins • 554 retina 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.